HealthEquity, Inc. (NASDAQ:HQY) Director Frank Medici sold 58,481 shares of the stock in a transaction dated Tuesday, November 21st. The shares were sold at an average price of $51.25, for a total transaction of $2,997,151.25. Following the completion of the transaction, the director now directly owns 6,381 shares of the company’s stock, valued at $327,026.25. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link.

Frank Medici also recently made the following trade(s):

  • On Friday, November 24th, Frank Medici sold 7,540 shares of HealthEquity stock. The shares were sold at an average price of $51.42, for a total transaction of $387,706.80.
  • On Wednesday, November 15th, Frank Medici sold 700 shares of HealthEquity stock. The shares were sold at an average price of $51.05, for a total transaction of $35,735.00.
  • On Friday, November 3rd, Frank Medici sold 32,404 shares of HealthEquity stock. The shares were sold at an average price of $51.09, for a total transaction of $1,655,520.36.
  • On Monday, November 6th, Frank Medici sold 419,504 shares of HealthEquity stock. The shares were sold at an average price of $52.97, for a total transaction of $22,221,126.88.
  • On Tuesday, October 24th, Frank Medici sold 7,900 shares of HealthEquity stock. The shares were sold at an average price of $51.11, for a total transaction of $403,769.00.
  • On Monday, October 9th, Frank Medici sold 316,644 shares of HealthEquity stock. The shares were sold at an average price of $51.96, for a total transaction of $16,452,822.24.

HealthEquity, Inc. (HQY) opened at $51.50 on Friday. HealthEquity, Inc. has a 12 month low of $37.62 and a 12 month high of $55.31. The firm has a market cap of $3,115.18, a P/E ratio of 81.75, a PEG ratio of 2.26 and a beta of 1.77.

HealthEquity (NASDAQ:HQY) last issued its quarterly earnings data on Tuesday, September 5th. The company reported $0.27 earnings per share for the quarter, topping the Zacks’ consensus estimate of $0.14 by $0.13. HealthEquity had a net margin of 20.27% and a return on equity of 13.93%. The business had revenue of $56.90 million during the quarter, compared to analysts’ expectations of $55.66 million. During the same period last year, the company posted $0.16 EPS. The company’s revenue was up 28.7% on a year-over-year basis. analysts anticipate that HealthEquity, Inc. will post 0.7 EPS for the current year.

A number of research analysts have issued reports on the stock. BidaskClub cut shares of HealthEquity from a “sell” rating to a “strong sell” rating in a report on Friday, August 25th. Cantor Fitzgerald reaffirmed a “buy” rating and issued a $56.00 target price on shares of HealthEquity in a report on Tuesday, September 5th. Zacks Investment Research cut shares of HealthEquity from a “buy” rating to a “hold” rating in a report on Friday, November 3rd. Oppenheimer Holdings, Inc. reaffirmed a “buy” rating and issued a $61.00 target price on shares of HealthEquity in a report on Wednesday, September 6th. Finally, Robert W. Baird reaffirmed a “hold” rating on shares of HealthEquity in a report on Thursday, September 21st. Three equities research analysts have rated the stock with a hold rating and eight have issued a buy rating to the company. HealthEquity has a consensus rating of “Buy” and a consensus target price of $57.50.

Institutional investors and hedge funds have recently modified their holdings of the company. Zions Bancorporation purchased a new stake in HealthEquity in the 3rd quarter worth approximately $119,000. Zurcher Kantonalbank Zurich Cantonalbank grew its stake in HealthEquity by 105.8% in the 2nd quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 2,544 shares of the company’s stock worth $127,000 after acquiring an additional 1,308 shares during the period. Riverhead Capital Management LLC grew its stake in HealthEquity by 75.3% in the 2nd quarter. Riverhead Capital Management LLC now owns 2,629 shares of the company’s stock worth $131,000 after acquiring an additional 1,129 shares during the period. Oppenheimer Asset Management Inc. grew its stake in HealthEquity by 7.7% in the 2nd quarter. Oppenheimer Asset Management Inc. now owns 2,686 shares of the company’s stock worth $134,000 after acquiring an additional 191 shares during the period. Finally, Fortaleza Asset Management Inc. purchased a new stake in HealthEquity in the 2nd quarter worth approximately $138,000. 93.19% of the stock is owned by institutional investors and hedge funds.

WARNING: “Frank Medici Sells 58,481 Shares of HealthEquity, Inc. (HQY) Stock” was posted by Watch List News and is the property of of Watch List News. If you are viewing this article on another site, it was illegally copied and reposted in violation of US & international trademark & copyright laws. The correct version of this article can be read at https://www.watchlistnews.com/frank-medici-sells-58481-shares-of-healthequity-inc-hqy-stock/1726825.html.

HealthEquity Company Profile

HealthEquity, Inc provides a range of solutions for managing healthcare accounts (Health Savings Accounts (HSAs), Health Reimbursement Arrangements (HRAs) and Flexible Spending Accounts (FSAs)) for health plans, insurance companies and third-party administrators. The Company is engaged in technology-enabled services platforms that allow consumers to make healthcare saving and spending decisions.

Insider Buying and Selling by Quarter for HealthEquity (NASDAQ:HQY)

Receive News & Ratings for HealthEquity Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HealthEquity Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.